Partially degradable particulates as time-released tracers for acidized and fractured gas wells
US-2024209729-A1 · Jun 27, 2024 · US
US10329478B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10329478-B2 |
| Application number | US-201415524870-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 18, 2014 |
| Priority date | Dec 18, 2014 |
| Publication date | Jun 25, 2019 |
| Grant date | Jun 25, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to systems and methods for using aldehydes as a catalyst for oxidative breakers. An embodiment of the present disclosure is a method comprising: providing a treatment fluid that comprises: an aqueous base fluid, a polymeric gelling agent, a breaker that comprises an oxidative salt, and a catalyst that comprises an aldehyde; allowing the breaker to interact with the polymeric gelling agent; and allowing the viscosity of the treatment fluid to reduce.
Opening claim text (preview).
What is claimed is: 1. A method comprising: providing a treatment fluid that consists essentially of: an aqueous base fluid, a polymeric gelling agent, a breaker that comprises at least one oxidative salt selected from the group consisting of: a chlorite salt, a chlorate salt, a perchlorate salt, and any combination thereof, wherein the breaker is present in the treatment fluid in a range of about 0.00625% to about 0.25% weight by weight, a catalyst that comprises at least one aldehyde selected from the group consisting of: glutaraldehyde, propionaldehyde, and any combination thereof, wherein the catalyst is present in the treatment fluid in a range of about 0.0025% to about 0.05% weight by weight; allowing the breaker to interact with the polymeric gelling agent in the presence of the catalyst at a temperature in a range of about 140° F. to about 200° F.; and allowing the viscosity of the treatment fluid to break in less than about 60 minutes. 2. The method of claim 1 wherein the aldehyde is glutaraldehyde. 3. The method of claim 1 wherein the polymeric gelling agent comprises at least one polymer selected from the group consisting of: alginate, chitosan, cyclosophoran, dextran, galactoglucopolysaccharide, gellan, glucuronan, N-acetyl-glucosamine, N-acetyl-heparosan, hyaluronic acid, indicant, kefiran, lentinan, levan, mauran, pullulan, scleroglucan, schizophyllan, stewartan, succinoglycan, xanthan, welan, starch, tamarind, tragacanth, guar gum, hydroxypropyl guar, carboxy methyl guar, carboxymethyl hydroxylpropyl guar, gum ghatti, gum arabic, locust bean gum, cellulose, carboxymethyl cellulose, hydroxyethyl cellulose, carboxymethyl hydroxyethyl cellulose, hydroxypropyl cellulose, methyl hydroxyl ethyl cellulose, acrylamide, acrylic acid, 2-acrylamido-2-methylpropane sulfonic acid, N,N-dimethylacrylamide, vinyl sulfonic acid, N-vinyl acetamide, N-vinyl formamide, itaconic acid, methacrylic acid, an acrylic acid ester, a methacrylic acid ester, quaternized aminoalkyl acrylate, poly(vinyl acetate), poly(vinyl alcohol), poly(ethylene glycol), and poly(vinyl pyrrolidone), and any combination thereof. 4. The method of claim 1 wherein at least a portion of the polymeric gelling agent is crosslinked by a crosslinking reaction comprising a crosslinking agent. 5. The method of claim 4 wherein the crosslinking agent comprises at least one crosslinking agent selected from the group consisting of: boric acid, disodium octaborate tetrahydrate, sodium diborate, pentaborates, ulexite, colemanite, zirconium lactate, zirconium lactate triethanolamine, zirconium carbonate, zirconium acetylacetonate, zirconium malate, zirconium citrate, zirconium diisopropylamine lactate, zirconium glycolate, titanium lactate, zirconium triethanol amine glycolate, zirconium lactate glycolate, zirconium triethanol amine, titanium malate, titanium citrate, titanium ammonium lactate, titanium triethanolamine, titanium acetylacetonate, aluminum lactate, aluminum citrate, an antimony compound, a chromium compound, an iron compound, any derivative thereof, and any combination thereof. 6. The method of claim 1 further comprising introducing the treatment fluid into at least a portion of a wellbore. 7. The method of claim 6 wherein the treatment fluid is introduced into the wellbore using one or more pumps. 8. The method of claim 1 , wherein the treatment fluid further contains at least one additional additive selected from the group consisting of: salts, surfactants, acids, proppant particulates, diverting agents, fluid loss control additives, gas, nitrogen, carbon dioxide, surface modifying agents, tackifying agents, foamers, corrosion inhibitors, scale inhibitors, clay control agents, biocides, friction reducers, antifoam agents, bridging agents, flocculants, additional H2S scavengers, CO2 scavengers, oxygen scavengers, lubricants, additional viscosifiers, weighting agents, relative permeability modifiers, resins, wetting agents, coating enhancement agents, filter cake removal agents, antifreeze agents, and any combination thereof. 9. A method comprising: introducing a treatment fluid into a portion of a subterranean formation, wherein the treatment fluid consists essentially of: an aqueous base fluid, a polymeric gelling agent, a breaker that comprises at least one oxidative salt selected from the group consisting of: a chlorite salt, a chlorate salt, a perchlorate salt, and any combination thereof, wherein the breaker is present in the treatment fluid in a range of about 0.00625% to about 0.25% weight by weight, and a catalyst that comprises at least one aldehyde selected from the group consisting of: glutaraldehyde, propionaldehyde, and any combination thereof, wherein the catalyst is present in the treatment fluid in a range of about 0.0025% to about 0.05% weight by weight; allowing the breaker to interact with the polymeric gelling agent in the presence of the catalyst at a temperature in a range of about 140° F. to about 200° F.; and allowing the viscosity of the treatment fluid to break in less than about 60 minutes. 10. The method of claim 9 wherein the aldehyde is glutaraldehyde. 11. The method of claim 9 wherein the polymeric gelling agent comprises at least one polymer selected from the group consisting of: alginate, chitosan, cyclosophoran, dextran, galactoglucopolysaccharide, gellan, glucuronan, N-acetyl-glucosamine, N-acetyl-heparosan, hyaluronic acid, indicant, kefiran, lentinan, levan, mauran, pullulan, scleroglucan, schizophyllan, stewartan, succinoglycan, xanthan, welan, starch, tamarind, tragacanth, guar gum, hydroxypropyl guar, carboxy methyl guar, carboxymethyl hydroxylpropyl guar, gum ghatti, gum arabic, locust bean gum, cellulose, carboxymethyl cellulose, hydroxyethyl cellulose, carboxymethyl hydroxyethyl cellulose, hydroxypropyl cellulose, methyl hydroxyl ethyl cellulose, acrylamide, acrylic acid, 2-acrylamido-2-methylpropane sulfonic acid, N,N-dimethylacrylamide, vinyl sulfonic acid, N-vinyl acetamide, N-vinyl formamide, itaconic acid, methacrylic acid, an acrylic acid ester, a methacrylic acid ester, quaternized aminoalkyl acrylate, poly(vinyl acetate), poly(vinyl alcohol), poly(ethylene glycol), and poly(vinyl pyrrolidone), and any combination thereof. 12. The method of claim 9 wherein at least a portion of the polymeric gelling agent is crosslinked by a crosslinking reaction comprising a crosslinking agent. 13. The method of claim 12 wherein the crosslinking agent comprises at least one crosslinking agent selected from the group consisting of: boric acid, disodium octaborate tetrahydrate, sodium diborate, pentaborates, ulexite, colemanite, zirconium lactate, zirconium lactate triethanolamine, zirconium carbonate, zirconium acetylacetonate, zirconium malate, zirconium citrate, zirconium diisopropylamine lactate, zirconium glycolate, titanium lactate, zirconium triethanol amine glycolate, zirconium lactate glycolate, zirconium triethanol amine, titanium malate, titanium citrate, titanium ammonium lactate, titanium triethanolamine, titanium acetylacetonate, aluminum lactate, aluminum citrate, an antimony compound, a chromium compound, an iron compound, any derivative thereof, and any combination thereof. 14. The method of claim 9 wherein the treatment fluid is introduced into the portion of the subterranean formation using one or more pumps. 15. The method of claim 9 wherein introducing the treatment fluid into the portion of the subterranean formation comprises introducing the treatment fluid at or above a pressure sufficient to create or enhance one or more fractures in the subterranean formation.
reinforcing fractures by propping · CPC title
characterised by their form or by the form of their components, e.g. encapsulated material (C09K8/70 takes precedence) · CPC title
characterised by their form or by the form of their components, e.g. foams · CPC title
macromolecular compounds · CPC title
containing cross-linking agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.